article thumbnail

FDA Approves Nitisinone for Treatment of Alkaptonuria

Drug Topics

The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The medication is expected to launch in July 2025. REFERENCES 1.

FDA 341
article thumbnail

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Drug Topics

The FDA approved insulin aspart-xjhz (Kirsty) 100 units/mL as the first and only interchangeable biosimilar to insulin aspart (NovoLog). 1 The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients. Sign up today for our free Drug Topics newsletter.

FDA 331
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Widaplik for Treatment of Hypertension

Drug Topics

The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. References 1.

FDA 281
article thumbnail

Once Monthly Oral PrEP Medication Will Advance to Phase 3 Study

Drug Topics

The primary outcomes included the number of individuals with HIV, the number of patients who experienced at least 1 adverse event (AE), and the number of participants who discontinued the study due to AEs. Investigators found that the rates of adverse events were similar for patients in the study drug groups and those in the placebo arm.

article thumbnail

Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform

Drug Topics

1 "Lilly was the first company to offer a self-pay solution for an FDA-approved obesity medication, and we continue to work to expand coverage for Zepbound. mg and 15 mg vials of tirzepatide starting July 7, with shipments beginning in early August.

article thumbnail

Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations

Drug Topics

It's also important for the general public to understand what these changes may mean for them and that there is a long-term impact on our health in the US as a result of these recent events. Sign up today for our free Drug Topics newsletter.

Vaccines 520
article thumbnail

A Team Effort Is Needed for Inventory Management | McKesson ideaShare

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)